ZG02 Improved Hepatic Glucose Metabolism and Insulin Sensitivity via Activation of AMPK/Sirt1 Signaling Pathways in a High-fat Diet/Streptozotocin-induced Type 2 Diabetes Model

Yi Zhang,1– 3 Bo Zhou,1,2,4 Min Wen,1 Mi Hu,1 Jin-Gang Peng,1– 3 Ying Wang,3 Lin-Lin Fan,1– 3 Lei Tang1– 3 1College of Basic Medical Sciences, Guizhou Medical University, Guizhou, 550004, People’s Republic of China; 2Engineering Technology Research C...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhang Y, Zhou B, Wen M, Hu M, Peng JG, Wang Y, Fan LL, Tang L
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/a45f550ad6e849bab1985a29ac886fbd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a45f550ad6e849bab1985a29ac886fbd
record_format dspace
spelling oai:doaj.org-article:a45f550ad6e849bab1985a29ac886fbd2021-12-02T12:18:31ZZG02 Improved Hepatic Glucose Metabolism and Insulin Sensitivity via Activation of AMPK/Sirt1 Signaling Pathways in a High-fat Diet/Streptozotocin-induced Type 2 Diabetes Model1178-7007https://doaj.org/article/a45f550ad6e849bab1985a29ac886fbd2020-11-01T00:00:00Zhttps://www.dovepress.com/zg02-improved-hepatic-glucose-metabolism-and-insulin-sensitivity-via-a-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Yi Zhang,1– 3 Bo Zhou,1,2,4 Min Wen,1 Mi Hu,1 Jin-Gang Peng,1– 3 Ying Wang,3 Lin-Lin Fan,1– 3 Lei Tang1– 3 1College of Basic Medical Sciences, Guizhou Medical University, Guizhou, 550004, People’s Republic of China; 2Engineering Technology Research Center for Chemical Drug R&D, Guizhou 550004, People’s Republic of China; 3College of Pharmacy, Guizhou Medical University, Guizhou 550004, People’s Republic of China; 4State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guizhou 550004, People’s Republic of ChinaCorrespondence: Lei Tang Tel +86 13308500332Email tlei1974@gmc.edu.cnPurpose: The aim of the present study was to investigate the hypoglycemic activity and potential mechanism of tetrahydrocarbazole derivatives ZG02 in high-fat diet/streptozotocin-induced type 2 diabetes model.Methods: C57BL/6 mice (n=30) were randomly assigned to three groups: control group (n=10) was fed with normal diet, the diabetes group (n=10) was fed with high-fat diet for eight weeks followed by intraperitoneal injection of streptozotocin (25 mg/kg) and the ZG02 group (n=10) injected intraperitoneally with ZG02 (30 mg/kg/day) for two weeks after successful modeling. The changes of weight, fasting blood glucose, oral glucose tolerance and fasting blood insulin levels in each group were evaluated. In addition, we also assessed the expression level of total AMPK, phosphorylation AMPK, SIRT1, PGC-1 and the activity of G6PC in liver.Results: The results demonstrated that ZG02 could significantly antagonize the high-fat diet/streptozotocin-induced fasting hyperglycemia, restore fasting blood insulin levels and also improve activity of G6PC in liver. The results from Western blot indicated that ZG02 significantly restored the expression level of phosphorylation AMPK, Sirt1 and PGC-1.Conclusion: ZG02 improve hepatic glucose metabolism and insulin sensitivity via activation AMPK/Sirt1 signaling pathways in type 2 diabetes mice model.Keywords: type 2 diabetes, glucose metabolism, ZG02, AMPK, high fatZhang YZhou BWen MHu MPeng JGWang YFan LLTang LDove Medical Pressarticletype 2 diabetesglucose metabolismzg02ampkhigh fatSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 13, Pp 4333-4339 (2020)
institution DOAJ
collection DOAJ
language EN
topic type 2 diabetes
glucose metabolism
zg02
ampk
high fat
Specialties of internal medicine
RC581-951
spellingShingle type 2 diabetes
glucose metabolism
zg02
ampk
high fat
Specialties of internal medicine
RC581-951
Zhang Y
Zhou B
Wen M
Hu M
Peng JG
Wang Y
Fan LL
Tang L
ZG02 Improved Hepatic Glucose Metabolism and Insulin Sensitivity via Activation of AMPK/Sirt1 Signaling Pathways in a High-fat Diet/Streptozotocin-induced Type 2 Diabetes Model
description Yi Zhang,1– 3 Bo Zhou,1,2,4 Min Wen,1 Mi Hu,1 Jin-Gang Peng,1– 3 Ying Wang,3 Lin-Lin Fan,1– 3 Lei Tang1– 3 1College of Basic Medical Sciences, Guizhou Medical University, Guizhou, 550004, People’s Republic of China; 2Engineering Technology Research Center for Chemical Drug R&D, Guizhou 550004, People’s Republic of China; 3College of Pharmacy, Guizhou Medical University, Guizhou 550004, People’s Republic of China; 4State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guizhou 550004, People’s Republic of ChinaCorrespondence: Lei Tang Tel +86 13308500332Email tlei1974@gmc.edu.cnPurpose: The aim of the present study was to investigate the hypoglycemic activity and potential mechanism of tetrahydrocarbazole derivatives ZG02 in high-fat diet/streptozotocin-induced type 2 diabetes model.Methods: C57BL/6 mice (n=30) were randomly assigned to three groups: control group (n=10) was fed with normal diet, the diabetes group (n=10) was fed with high-fat diet for eight weeks followed by intraperitoneal injection of streptozotocin (25 mg/kg) and the ZG02 group (n=10) injected intraperitoneally with ZG02 (30 mg/kg/day) for two weeks after successful modeling. The changes of weight, fasting blood glucose, oral glucose tolerance and fasting blood insulin levels in each group were evaluated. In addition, we also assessed the expression level of total AMPK, phosphorylation AMPK, SIRT1, PGC-1 and the activity of G6PC in liver.Results: The results demonstrated that ZG02 could significantly antagonize the high-fat diet/streptozotocin-induced fasting hyperglycemia, restore fasting blood insulin levels and also improve activity of G6PC in liver. The results from Western blot indicated that ZG02 significantly restored the expression level of phosphorylation AMPK, Sirt1 and PGC-1.Conclusion: ZG02 improve hepatic glucose metabolism and insulin sensitivity via activation AMPK/Sirt1 signaling pathways in type 2 diabetes mice model.Keywords: type 2 diabetes, glucose metabolism, ZG02, AMPK, high fat
format article
author Zhang Y
Zhou B
Wen M
Hu M
Peng JG
Wang Y
Fan LL
Tang L
author_facet Zhang Y
Zhou B
Wen M
Hu M
Peng JG
Wang Y
Fan LL
Tang L
author_sort Zhang Y
title ZG02 Improved Hepatic Glucose Metabolism and Insulin Sensitivity via Activation of AMPK/Sirt1 Signaling Pathways in a High-fat Diet/Streptozotocin-induced Type 2 Diabetes Model
title_short ZG02 Improved Hepatic Glucose Metabolism and Insulin Sensitivity via Activation of AMPK/Sirt1 Signaling Pathways in a High-fat Diet/Streptozotocin-induced Type 2 Diabetes Model
title_full ZG02 Improved Hepatic Glucose Metabolism and Insulin Sensitivity via Activation of AMPK/Sirt1 Signaling Pathways in a High-fat Diet/Streptozotocin-induced Type 2 Diabetes Model
title_fullStr ZG02 Improved Hepatic Glucose Metabolism and Insulin Sensitivity via Activation of AMPK/Sirt1 Signaling Pathways in a High-fat Diet/Streptozotocin-induced Type 2 Diabetes Model
title_full_unstemmed ZG02 Improved Hepatic Glucose Metabolism and Insulin Sensitivity via Activation of AMPK/Sirt1 Signaling Pathways in a High-fat Diet/Streptozotocin-induced Type 2 Diabetes Model
title_sort zg02 improved hepatic glucose metabolism and insulin sensitivity via activation of ampk/sirt1 signaling pathways in a high-fat diet/streptozotocin-induced type 2 diabetes model
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/a45f550ad6e849bab1985a29ac886fbd
work_keys_str_mv AT zhangy zg02improvedhepaticglucosemetabolismandinsulinsensitivityviaactivationofampksirt1signalingpathwaysinahighfatdietstreptozotocininducedtype2diabetesmodel
AT zhoub zg02improvedhepaticglucosemetabolismandinsulinsensitivityviaactivationofampksirt1signalingpathwaysinahighfatdietstreptozotocininducedtype2diabetesmodel
AT wenm zg02improvedhepaticglucosemetabolismandinsulinsensitivityviaactivationofampksirt1signalingpathwaysinahighfatdietstreptozotocininducedtype2diabetesmodel
AT hum zg02improvedhepaticglucosemetabolismandinsulinsensitivityviaactivationofampksirt1signalingpathwaysinahighfatdietstreptozotocininducedtype2diabetesmodel
AT pengjg zg02improvedhepaticglucosemetabolismandinsulinsensitivityviaactivationofampksirt1signalingpathwaysinahighfatdietstreptozotocininducedtype2diabetesmodel
AT wangy zg02improvedhepaticglucosemetabolismandinsulinsensitivityviaactivationofampksirt1signalingpathwaysinahighfatdietstreptozotocininducedtype2diabetesmodel
AT fanll zg02improvedhepaticglucosemetabolismandinsulinsensitivityviaactivationofampksirt1signalingpathwaysinahighfatdietstreptozotocininducedtype2diabetesmodel
AT tangl zg02improvedhepaticglucosemetabolismandinsulinsensitivityviaactivationofampksirt1signalingpathwaysinahighfatdietstreptozotocininducedtype2diabetesmodel
_version_ 1718394529778761728